Craniospinal radiotherapy in adult medulloblastoma

Strahlentherapie und Onkologie

Volumn 183, Issue 5, 2007, Pages 236-240

  Selek, Ugur ^a   Zorlu, Faruk ^a   Hurmuz, Pervin ^a   Cengiz, Mustafa ^a   Turker, Alev ^a   Soylemezoglu, Figen ^a   Gurkaynak, Murat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adult; Chemotherapy; Medulloblastoma; Radiotherapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER SURGERY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDULLOBLASTOMA; MORBIDITY; OUTCOME ASSESSMENT; PATIENT CODING; POSTERIOR CRANIAL FOSSA TUMOR; PROGNOSIS; RECURRENT DISEASE; SURVIVAL RATE; TUMOR CLASSIFICATION; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; CEREBELLAR NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SPINE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34248182443     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1563-y     Document Type: Article

References (39)

1. Abacioglu U, Uzel O, Sengoz M, et al. Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2002;54:855-60.
2. Albright AL, Wisoff JH, Zeltzer PM. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery 1996;38:265-71.
3. Bloom HJ. Medulloblastoma: prognosis and prospects. Int J Radiat Oncol Biol Phys 1977;2:1031-3.
4. Brandes AA, Palmisano V, Monfardini S. Medulloblastoma in adults: clinical characteristics and treatment. Cancer Treat Rev 1999;25:3-12.
5. Carrie C, Lasset C, Alapetite C, et al. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients. Cancer 1994;74:2352-60.
6. Carrie C, Muracciole X, Gomez F, et al. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 2005;63:711-6.
7. Chan AW, Tarbell NJ, Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000;47:623-31, discussion 631-2.
8. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969;93:1351-9.
9. Cozzi L, Clivio A, Vanetti E, et al. Comparative planning study for proton radiotherapy of benign brain tumors. Strahlenther Onkol 2006;182:376-81.
10. Frost PJ, Laperriere NJ, Wong CS, et al. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:951-7.
11. Gajjar AJ, Heideman RL, Douglass EC, et al. Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 1993;11:2211-7.
12. Giordana MT, Duo D, Gasverde S, et al. MDM2 overexpression is associated with short survival in adults with medulloblastoma. Neurooncology 2002;4:115-22.
13. Giordana MT, Schiffer P, Lanotte M, et al. Epidemiology of adult medulloblastoma. Int J Cancer 1999;80:689-92.
14. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S. Adult medulloblastoma: multiagent chemotherapy. Neuro-oncol 2001;3:29-34.
15. Grotzer MA, Hogarty MD, Janss AJ, et al. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 2001;7:2425-33.
16. Grotzer MA, Janss AJ, Fung K, et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 2000;18:1027-35.
17. Herrlinger U, Steinbrecher A, Rieger J, et al. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol 2005;252:291-9.
18. Hinsdale IL. CBTRUS. Statistical Report: Primary brain tumors in the United States, 1995-1999. Published by the Central Brain Tumor Registry of the United States. 2002;32.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:447-57.
20. Kocher M, Eich H-T, Semrau R, et al. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases. Strahlenther Onkol 2005;181:20-5.
21. Kocsis B, Szekely G, Pap L, et al. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma. Strahlenther Onkol 2003;179:854-9.
22. Kortmann RD, Kuhl J, Timmermann B, et al. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood.] Strahlenther Onkol 2001;177:447-61.
23. Kunschner LJ, Kuttesch J, Hess K, et al. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neurooncology 2001;3:167-73.
24. Lamont JM, McManamy CS, Pearson AD, et al. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients. Clin Cancer Res 2004;10:5482-93.
25. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology study. J Clin Oncol 2005;23:4726-34.
26. Packer RJ. Is postoperative chemotherapy alone sufficient to treat young children with medulloblastoma? Nat Clin Pract Oncol 2005;2:386-7.
27. Packer RJ, Sutton LN, Elterman R. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-8.
28. Peterson K, Walker RW. Medulloblastoma/primitive neuroectodermal tumor in 45 adults. Neurology 1995;45:440-2.
29. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-42.
30. Prados MD, Warnick RE, Wara WM, et al. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:1145-52.
31. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-86.
32. Rutz HP, Lomax AJ. Donut-shaped high-dose configuration for proton beam radiation therapy. Strahlenther Onkol 2005;181:49-53.
33. Schofield DE, Yunis EJ, Geyer JR, et al. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system. Cancer 1992;69:1307-14.
34. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003;21:1581-91.
35. Tomita T, Yasue M, Engelhard HH, et al. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy. Cancer 1988;61:744-9.
36. Welzel G, Steinvorth S, Wenz F. Cognitive effects of chemotherapy and/or cranial irradiation in adults. Strahlenther Onkol 2005;181:141-56.
37. Yao MS, Mehta MP, Boyett JM, et al. The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population. Int J Radiat Oncol Biol Phys 1997;38:469-76.
38. Yasue M, Tomita T, Engelhard H, et al. Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 1989;70:385-91.
39. Zerbini C, Gelber RD, Weinberg D, et al. Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 1993;11:616-22.